Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
29.18
+0.16 (0.55%)
Jan 29, 2026, 11:47 AM EST - Market open
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $2.88 billion as of January 29, 2026. Its market cap has increased by 37.11% in one year.
Market Cap
2.88B
Enterprise Value
1.94B
1-Year Change
37.11%
Ranking
Category
Stock Price
$29.18
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $2.88B, an increase of 778.08%. That is a compound annual growth rate of 43.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 3.03B | 10.75% |
| Dec 31, 2025 | 2.74B | 38.60% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Erasca | 3.23B |
| Alumis | 3.22B |
| Arcutis Biotherapeutics | 3.21B |
| Viridian Therapeutics | 3.15B |
| IDEAYA Biosciences | 3.06B |
| Edgewise Therapeutics | 3.06B |
| Disc Medicine | 3.03B |
| Dyne Therapeutics | 2.96B |